Which product should an adolescent with hemophilia A receive before wisdom teeth extraction?

An adolescent with hemophilia A should receive recombinant clotting factor before a procedure like wisdom teeth extraction to prevent excessive bleeding. Hemophilia A is a genetic disorder characterized by a deficiency in clotting factor VIII, which is essential for normal blood clotting. Recombinant factor VIII provides the necessary replacement for the missing clotting factor, enabling the blood to coagulate properly during and after the extraction. This preemptive measure helps manage bleeding risks associated with surgical procedures.

Packed red blood cells are used for transfusions in cases of severe anemia or significant blood loss but do not address the specific clotting factor deficiency in hemophilia A. Prophylactic antibiotics may be indicated for preventing infection post-procedure but do not address the hemostatic concerns related to hemophilia. Fresh frozen plasma contains various clotting factors but is not the preferred choice for treating hemophilia A specifically, as it does not provide a concentrated dose of factor VIII needed for effective management of bleeding during surgery.